Ascentage Pharma Group Inc.
Clinical trials sponsored by Ascentage Pharma Group Inc., explained in plain language.
Biopharmaceutical company developing targeted cancer therapies.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New pill shows promise for tough blood cancers Results expected Dec 2026 (estimated)
- New combo therapy aims to outsmart resistant blood cancer Results expected Dec 2026 (estimated) 🚀 Make-or-break
- Can a targeted pill shrink a rare, Treatment-Resistant stomach cancer? Results expected Mar 2027 (estimated)
- Experimental pill takes on Hard-to-Treat ovarian cancer Results expected May 2027 (estimated)
- Can a drug duo outsmart resistant tumors? Results expected Jun 2027 (estimated)
-
Cancer combo trial halted before full results
Disease control Stopped earlyThis early-stage trial tested a combination of two drugs, APG-1387 and toripalimab, in 40 people with advanced solid tumors including colorectal, nasopharyngeal, and lung cancers. The goal was to find a safe dose and see if the combination could control the disease. However, the …
Phase 1/2 • Sponsor: Ascentage Pharma Group Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Experimental pancreatic cancer combo trial halted early
Disease control Stopped earlyThis study tested an experimental drug called APG-1387 combined with standard chemotherapy (gemcitabine and nab-paclitaxel) in people with advanced pancreatic cancer. The goal was to find the safest dose and see if the combination could shrink tumors. However, the trial was termi…
Phase 1/2 • Sponsor: Ascentage Pharma Group Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC